Evidence map›Paper›PMID 34464485›Full record

Trial reportDepression and anxiety2022

Transcranial direct current stimulation targeting the medial prefrontal cortex modulates functional connectivity and enhances safety learning in obsessive-compulsive disorder: Results from two pilot studies.

Thomas G Adams, Josh M Cisler, Benjamin Kelmendi, Jamilah R George, Stephen A Kichuk, Christopher L Averill, Alan Anticevic, Chadi G Abdallah, Christopher Pittenger

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Depression and anxiety, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Multisession tDCS combined with intrastimulation training improves emotion recognition in adolescents with autism spectrum disorder.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024
    Trial
  5. Trial
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Thomas G AdamsDepartment of Psychology, University of Kentucky, Lexington, Kentucky, USA.ORCID 0000-0001-5404-658X
Josh M CislerDepartment of Psychiatry, University of Wisconsin, Madison, Wisconsin, USA.
Benjamin KelmendiDepartment of Psychiatry, School of Medicine, Yale University, New Haven, Connecticut, USA.
Jamilah R GeorgeDepartment of Psychiatry, School of Medicine, Yale University, New Haven, Connecticut, USA.
Stephen A KichukDepartment of Psychiatry, School of Medicine, Yale University, New Haven, Connecticut, USA.
Christopher L AverillDepartment of Psychiatry, School of Medicine, Yale University, New Haven, Connecticut, USA.ORCID 0000-0001-7575-6142
Alan AnticevicDepartment of Psychiatry, School of Medicine, Yale University, New Haven, Connecticut, USA.
Chadi G AbdallahDepartment of Psychiatry, School of Medicine, Yale University, New Haven, Connecticut, USA.
Christopher PittengerDepartment of Psychiatry, School of Medicine, Yale University, New Haven, Connecticut, USA.
Yale University · USMichael E. DeBakey VA Medical Center · USUniversity of Connecticut · USUniversity of Kentucky · USUniversity of Wisconsin–Madison · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCDR01MH116038 · NIMH · YALE UNIVERSITY · PI ANTICEVIC, ALAN, PITTENGER, CHRISTOPHER JOHN · 2019 to 2023
$3.7M
Research Training in Functional Disability InterventionsT32MH062994 · NIMH · YALE UNIVERSITY · PI BELL, MORRIS D. · 2002 to 2017
$3.0M
Characterizing Schizophrenia Progression via Multi-modal Neuroimaging and ComputationR01MH108590 · NIMH · YALE UNIVERSITY · PI ANTICEVIC, ALAN · 2016 to 2020
$2.0M
Enhancement of extinction learning using transcranial direct current stimunationK23MH111977 · NIMH · YALE UNIVERSITY · PI ADAMS, THOMAS G · 2017 to 2021
$942k
Patient Oriented Research and Mentorship and Training in Functional Neuroimaging of Obsessive-Compulsive DisorderK24MH121571 · NIMH · YALE UNIVERSITY · PI PITTENGER, CHRISTOPHER JOHN · 2020 to 2024
$900k
NCATS NIH HHS UL1 TR001863NIMH NIH HHS K23 MH111977NIMH NIH HHS K24 MH121571NIMH NIH HHS L30 MH111037NIMH NIH HHS R01 MH108590NIMH NIH HHS R01 MH116038NIMH NIH HHS T32 MH062994
6 · The paper itself

Abstract

backgroundExposed-based psychotherapy is a mainstay of treatment for obsessive-compulsive disorder (OCD) and anxious psychopathology. The medial prefrontal cortex (mPFC) and the default mode network (DMN), which is anchored by the mPFC, promote safety learning. Neuromodulation targeting the mPFC might augment therapeutic safety learning and enhance response to exposure-based therapies.

methodsTo characterize the effects of mPFC neuromodulation on functional connectivity, 17 community volunteers completed resting-state functional magnetic resonance imaging scans before and after 20 min of frontopolar anodal multifocal transcranial direct current stimulation (tDCS). To examine the effects of tDCS on therapeutic safety learning, 24 patients with OCD completed a pilot randomized clinical trial; they were randomly assigned (double-blind, 50:50) to receive active or sham frontopolar tDCS before completing an in vivo exposure and response prevention (ERP) challenge. Changes in subjective emotional distress during the ERP challenge were used to index therapeutic safety learning.

resultsIn community volunteers, frontal pole functional connectivity with the middle and superior frontal gyri increased, while connectivity with the anterior insula and basal ganglia decreased (ps < .001, corrected) after tDCS; functional connectivity between DMN and salience network also decreased after tDCS (ps < .001, corrected). OCD patients who received active tDCS exhibited more rapid therapeutic safety learning (ps < .05) during the ERP challenge than patients who received sham tDCS.

conclusionsFrontopolar tDCS may modulate mPFC and DMN functional connectivity and can accelerate therapeutic safety learning. Though limited by small samples, these findings motivate further exploration of the effects of frontopolar tDCS on neural and behavioral targets associated with exposure-based psychotherapies.

Indexed as

Obsessive-Compulsive DisorderTranscranial Direct Current StimulationHumansMagnetic Resonance ImagingPilot ProjectsPrefrontal Cortexbehavior therapybrain stimulationcognitive behavior therapy (CBT)obsessive-compulsive disorder (OCD)TMS/DBS/VNS

Identifiers

PMID34464485
PMCPMC8732293
OpenAlexW3198281522

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.